On the recordFebruary 8, 2012
Now, one obstacle for ensuring comparable inspections of domestic and foreign facilities is a lack of complete and accurate information that FDA has on generic drug manufacturing establishments.
Source
congress.govJohn Dingell: “Now, one obstacle for ensuring comparable inspections of domestic and foreign facilities is a lack of complete and…”
Editor's note · Context
Dingell identifies lack of information as a barrier to effective inspections.
Share
More from John Dingell
Jul 22, 2014
This year is the 80th Anniversary of the issuance of the first Federal Duck Stamp.
Other voices in this conversation
